AzTrials
AzTrials

Incisional HerniaEVENTRALAPNCT00970515

Laparoscopic or Conventional Mesh Repair of Incisional and Umbilical Hernia

A study testing Laparoscopic mesh hernia repair and Open anterior approach in people with Incisional Hernia and Umbilical Hernia, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The aim of this study is to compare immediate and long-term (24 months) results of laparoscopic and open mesh repair of incisional and umbilical hernia. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Incisional Hernia, Umbilical Hernia
What is being tested?
Laparoscopic mesh hernia repair and Open anterior approach
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
98 participants
Where
1 siteFrance
Study dates
Nov 2009to Apr 2013
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age > 18
  • Incisional or umbilical hernia over 2 cm and less than 6 cm in diameter

Who cannot join

  • Patients with a complicated incisional (pain, occlusion, cutaneous necrosis), irreductible painless incisional or umbilical hernia will not be considered as a complication
  • Patients with a recurrence of incisional hernia
  • Patients with an incisional or umbilical hernia whose lateral edges are located so that fixation of the mesh (which must extend beyond the 4 to 5 cm) is not possible
  • Pregnant women
  • Patients with HIV therapy
  • Patients with cirrhotic ascites or other signs of hepatic insufficiency (bilirubin> 35 micromol / l; TP < 55%) or significant thrombocytopenia (< 60 000 platelets)
Show all 9Show fewer
  • Patients with a contra indication for laparoscopy
  • Patients with a life expectancy < one year, or whose mobility within two years of treatment will damage proper monitoring
  • Patients unable to understand information about the protocol

Trial locations and contacts

1 site in 1 country.

France1 site
  • Hôpital Jean Verdier, department of digestive and general surgery

    Bondy, 93140

Other trials in France

About this study

Official title: A Prospective, Multicenter, Randomized Trial Comparing Laparoscopy VS Conventional Mesh Repair of Incisional and Umbilical Hernia

The aim of this study is to compare immediate and long-term (24 months) results of laparoscopic and open mesh repair of incisional and umbilical hernia.

Read the detailed description

The aim of this study is to compare immediate and long-term (24 months) results of laparoscopic and open mesh repair of incisional and umbilical hernia.

Five hundred patients will be included in this randomized, multicentric trial.

Hypotheses are that laparoscopic approach: 1- reduces immediate parietal complications without increasing intra abdominal septic complications 2- is less invasive and also reduces patients' hospital stay and recovery time; 3- has the same efficacy, than open approach.

Being tested
Laparoscopic mesh hernia repair, Open anterior approach
Keywords
Laparoscopy, Incisional hernia, Umbilical hernia, Mesh repair, Postoperative complications
Medical subject headings
Incisional Hernia, Hernia, Umbilical, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Laparoscopic mesh hernia repairProcedure or surgery

    Also called laparoscpic mesh repair of incisional and umbilical hernia

    The mesh is intraperitoneal

  • Open anterior approachProcedure or surgery

    Also called Conventional treatment of incisional and umbilical hernia

    The mesh is placed by an anterior approach. It is placed after incision of the skin over or under the abdominal muscles, or is intraperitoneal

Study groups in NCT00970515
Study groupRoleWhat they receive
Laparoscopic approachExperimentalgroup A: Laparoscopic approach
Receives: Procedure: Laparoscopic mesh hernia repair
Open approachActive comparatorgroup B: Open anterior approach
Receives: Procedure: Open anterior approach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Parietal postoperative complications: 1- haematoma, 2- abscess, 3- seroma 4- cutaneous necrosis

    Measured: 2 months

  2. Postoperative intra abdominal complications: peritonitis, occlusion, haemorrhage

    Measured: 2 months

Secondary outcomes (13)
  1. Postoperative pain: measured by a- Visual Analogic Score (VAS 0-10): 1-number of days with VAS > 5; 2- maximal VAS, and b- duration (days) of morphine use

    Measured: 2 months

  2. Postoperative fever > 38°5

    Measured: 2 months

  3. Postoperative ileus

    Measured: 2 months

  4. Postoperative phlebitis

    Measured: 2 months

  5. Postoperative pulmonary embolism

    Measured: 2 months

  6. Postoperative urinary infection

    Measured: 2 months

  7. Duration of hospital stay

    Measured: 2 months

  8. Duration of drainage

    Measured: 2 months

  9. Mesh infection

    Measured: 24 months

  10. Peritonitis due to intraperitoneal mesh

    Measured: 24 months

  11. Occlusion due to intra peritoneal mesh

    Measured: 2 months

  12. Recurrence of incisional or umbilical hernia

    Measured: 24 months

  13. Trocar site hernia

    Measured: 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Sep 2009 (estimated)
  2. Study startNov 2009
  3. Primary completionApr 2011
  4. Study completionApr 2013

Why it stopped: lack of recrutment

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
98 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00970515
Sponsor's protocol ID
K060214
Other IDs
2007-A00374-49
Acronym
EVENTRALAP
Status last verified
Jun 2021
First submitted
1 Sep 2009
Last updated
18 Jun 2021
Results posted
No
Data monitoring committee
Yes

Publications

  • Slim K, Vons C. [Inguinal hernia repair: results of randomized clinical trials and meta-analyses]. J Chir (Paris). 2008 Mar-Apr;145(2):122-5. doi: 10.1016/s0021-7697(08)73720-7. French.

    PubMed 18645551
  • Vons C. [Laparoscopic treatment of ventral hernias]. J Chir (Paris). 2004 Nov;141(6):366-70. doi: 10.1016/s0021-7697(04)95361-6. No abstract available. French.

    PubMed 15738845
  • Proske JM, Vons C. [Laparoscopic treatment of ventral hernias]. J Chir (Paris). 2004 Nov;141(6):360-4. doi: 10.1016/s0021-7697(04)95360-4. French.

    PubMed 15738844

Questions about this trial

What is this clinical trial studying?

A study testing Laparoscopic mesh hernia repair and Open anterior approach in people with Incisional Hernia and Umbilical Hernia, run by Assistance Publique - Hôpitaux de Paris at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: lack of recrutment). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Parietal postoperative complications: 1- haematoma, 2- abscess, 3- seroma 4- cutaneous necrosis (time frame: 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00970515, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in